Supriya Lifescience Limited (BOM:543434)

India flag India · Delayed Price · Currency is INR
620.45
+1.35 (0.22%)
At close: Apr 21, 2026
Market Cap49.96B -16.5%
Revenue (ttm)7.35B +9.7%
Net Income1.85B +6.2%
EPS23.04 +6.4%
Shares Outn/a
PE Ratio26.97
Forward PE21.12
Dividend1.00 (0.16%)
Ex-Dividend DateSep 4, 2025
Volume2,518
Average Volume7,795
Open619.00
Previous Close619.10
Day's Range618.90 - 629.15
52-Week Range545.65 - 831.00
Betan/a
RSI50.08
Earnings DateMay 26, 2026

About Supriya Lifescience

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, ... [Read more]

Industry Pharmaceutical Preparations
Founded 1987
Employees 515
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543434
Full Company Profile

Financial Performance

In fiscal year 2025, Supriya Lifescience's revenue was 6.96 billion, an increase of 22.12% compared to the previous year's 5.70 billion. Earnings were 1.88 billion, an increase of 57.80%.

Financial Statements